Home/Filings/4/0001209191-23-002437
4//SEC Filing

DesJardin Michael A. 4

Accession 0001209191-23-002437

CIK 0001492426other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:52 PM ET

Size

24.6 KB

Accession

0001209191-23-002437

Insider Transaction Report

Form 4
Period: 2023-01-04
DesJardin Michael A.
EVP, Technical Operations
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2023-01-05+54,253149,087 total
  • Award

    Restricted Stock Units (RSUs)

    2023-01-04+20,69720,697 total
    Ordinary Shares (20,697 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSUs)

    2023-01-0512,0950 total
    Ordinary Shares (12,095 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSUs)

    2023-01-0510,47810,479 total
    Ordinary Shares (10,478 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSUs)

    2023-01-057,14114,283 total
    Ordinary Shares (7,141 underlying)
  • Exercise/Conversion

    Performance Restricted Stock Units (PSUs)

    2023-01-057,2570 total
    Ordinary Shares (7,257 underlying)
  • Exercise/Conversion

    Performance Restricted Stock Units (PSUs)

    2023-01-051,9660 total
    Ordinary Shares (1,966 underlying)
  • Exercise/Conversion

    Performance Restricted Stock Units (PSUs)

    2023-01-054,8340 total
    Ordinary Shares (4,834 underlying)
  • Exercise/Conversion

    Performance Restricted Stock Units (PSUs)

    2023-01-0510,4825,236 total
    Ordinary Shares (10,482 underlying)
  • Tax Payment

    Ordinary Shares

    2023-01-05$113.24/sh26,901$3,046,269122,186 total
Footnotes (7)
  • [F1]Each RSU/PSU represents a contingent right to receive one ordinary share of the Issuer.
  • [F2]The RSUs vest 1/3rd annually on each anniversary of January 5, 2023.
  • [F3]The final tranche of ordinary shares subject to the RSU vested on January 5, 2023.
  • [F4]The remaining ordinary shares subject to the RSU vest on January 5, 2024.
  • [F5]The remaining ordinary shares subject to the RSV vest ratably on January 5, 2024 and January 5, 2025.
  • [F6]The ordinary shares subject to the PSUs vested on January 5, 2023.
  • [F7]The remaining ordinary shares subject to the PSU vest on January 5, 2024.

Issuer

Horizon Therapeutics Public Ltd Co

CIK 0001492426

Entity typeother

Related Parties

1
  • filerCIK 0001512985

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:52 PM ET
Size
24.6 KB